Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Enanta Pharmaceuticals (ENTA) Shares Outstanding (2016 - 2025)

Enanta Pharmaceuticals' Shares Outstanding history spans 14 years, with the latest figure at $29.0 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 36.03% year-over-year to $29.0 million; the TTM value through Dec 2025 reached $29.0 million, up 36.03%, while the annual FY2025 figure was $21.4 million, 0.0% changed from the prior year.
  • Shares Outstanding reached $29.0 million in Q4 2025 per ENTA's latest filing, up from $21.4 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $29.0 million in Q4 2025 to a low of $20.2 million in Q1 2021.
  • Average Shares Outstanding over 5 years is $21.3 million, with a median of $21.1 million recorded in 2023.
  • The largest YoY upside for Shares Outstanding was 36.03% in 2025 against a maximum downside of 0.0% in 2025.
  • A 5-year view of Shares Outstanding shows it stood at $20.5 million in 2021, then grew by 1.84% to $20.9 million in 2022, then rose by 1.3% to $21.2 million in 2023, then grew by 0.84% to $21.3 million in 2024, then skyrocketed by 36.03% to $29.0 million in 2025.
  • Per Business Quant, the three most recent readings for ENTA's Shares Outstanding are $29.0 million (Q4 2025), $21.4 million (Q3 2025), and $21.4 million (Q2 2025).